ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Mild Water-Filtered Near Infrared Whole-Body-Hyperthermia as an Adjunct in the Treatment of Fibromyalgia

This study has been completed.

Sponsored by: Forschungsinstitut für Balneologie und Kurortwissenschaft Bad Elster
Information provided by: Forschungsinstitut für Balneologie und Kurortwissenschaft Bad Elster
ClinicalTrials.gov Identifier: NCT00324441
  Purpose

The purpose of the study is to evaluate whether mild walter-filtered near infrared hyperthermia produces an additional benefit when applied as an adjunct to standard multimodal rehabilitation compared to standard multimodal rehabilitation only in patients with fibromyalgia.


Condition Intervention Phase
Fibromyalgia
Device: Iratherm® 1000
Phase II

MedlinePlus related topics:   Drinking Water    Fever    Fibromyalgia    Rehabilitation   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Official Title:   A Randomized Controlled Trial on the Effectiveness of Mild Water-Filtered Near Infrared Hyperthermia as an Adjunct to a Standard Multimodal Rehabilitation in the Treatment of Fibromyalgia

Further study details as provided by Forschungsinstitut für Balneologie und Kurortwissenschaft Bad Elster:

Primary Outcome Measures:
  • affective pain (German version of the McGill Pain Questionnaire)
  • sensory pain (German version of the McGill Pain Questionnaire)

Secondary Outcome Measures:
  • pain intensity (visual analogue scale)
  • Fibromyalgia related quality of life(German version of the Fibromyalgia Impact Questionnaire)
  • tender point assessment(mean tender point pain threshold, total tender point intensity, tender point count)
  • adverse events, side effects

Estimated Enrollment:   132
Study Start Date:   January 2004
Estimated Study Completion Date:   July 2005

Detailed Description:

Mild systemic heat agents, including infrared whole-body hyperthermia, are used as treatment options in multimodal rehabilitation programs for fibromyalgia in Germany. However, no randomized controlled clinical trial exists on their effectiveness for this condition.

This study is designed as an add-on study to evaluate the additional benefit of mild walter-filtered near infrared hyperthermia and a standard multimodal rehabilitation program compared to a standard multimodal rehabilitation program only. Standard multimodal rehabilitation is configured as usually applied in clinical trials with exercise, cognitive behavioral therapy, and health education as the main treatment components.

Mild walter-filtered near infrared hyperthermia (heating-up to 38.1 degrees C body core temperature followed by a 15-min heat retention period) is administered twice a week over 3 weeks during a rehabilitation hospital stay.

Primary outcome measures are measured at baseline, postintervention, 3 and 6 months postintervention. Analysis is done by intention to treat, for significance testing Repeated Measures ANCOVA is used.

  Eligibility
Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  • participants must meet the American College of Rheumatology 1990 criteria for fibromyalgia
  • participants must report a score ≥ 4 on the pain intensity subscale of the Fibromyalgia Impact Questionnaire (range: 0-10)
  • participants must report a score ≥ 4 on the normalized physical functioning subscale of the Fibromyalgia Impact Questionnaire (range: 0-10)
  • participants must be aged between 18 and 70 years

Exclusion Criteria:

  • severe cardiovascular disease
  • metabolic disease
  • nervous system disorder
  • blood coagulation disease
  • cancer
  • acute inflammatory disease
  • status after organ transplantation
  • reduced general health (Karnofsky Index ≤ 50)
  • pregnant women
  • breast feeding women
  • persons involved in a pending litigation for early pensioning due to fibromyalgia
  • persons planning to apply for a pension due to fibromyalgia
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00324441

Locations
Germany, Hessen
Rehabilitationsklinik Hoher Meissner    
      Bad Sooden-Allendorf, Hessen, Germany, 37242

Sponsors and Collaborators
Forschungsinstitut für Balneologie und Kurortwissenschaft Bad Elster

Investigators
Study Chair:     Thomas Brockow, MD     FBK Bad Elster    
  More Information

Study ID Numbers:   WBH-FM-1
First Received:   May 9, 2006
Last Updated:   May 9, 2006
ClinicalTrials.gov Identifier:   NCT00324441
Health Authority:   Germany: Federal Institute for Drugs and Medical Devices

Keywords provided by Forschungsinstitut für Balneologie und Kurortwissenschaft Bad Elster:
Fibromyalgia  
Rehabilitation  
Physical Medicine  
Whole-Body Hyperthermia  
Water-Filtered Near Infrared  

Study placed in the following topic categories:
Fever
Signs and Symptoms
Muscular Diseases
Neuromuscular Diseases
Musculoskeletal Diseases
Myofascial Pain Syndromes
Fibromyalgia
Pain
Rheumatic Diseases

Additional relevant MeSH terms:
Nervous System Diseases
Body Temperature Changes

ClinicalTrials.gov processed this record on August 20, 2008




Links to all studies - primarily for crawlers